Phosphorylation of mTOR is increased in response to leucine [20], an excellent substrate for SLC6A14; as such, our findings that
mTOR phosphorylation is markedly decreased in Slc6a14 − / − tumours indicate that the tumours suffer from amino acid deprivation.
Chiang and Abraham (43) have recently shown that
mTOR phosphorylation at Ser2448 is blocked by rapamycin, and this effect is independent of AKT activation status.
AKT activation contributes to
mTOR phosphorylation in ALCL cells.
C and D, inhibition of AKT1 expression or activity decreases
mTOR phosphorylation.
Not exact matches
Binding of raptor to
mTOR is necessary for
phosphorylation of 4E - BP1 and p70S6K (Fig. 7).
The
phosphorylation status of all
mTOR signaling proteins was determined as negative, positive, and strongly positive (+ +) depending on the presence and staining intensity of signal (Table 1).
Because treatment with rapamycin also led to decreased AKT
phosphorylation in ALK + ALCL cells in our in vitro study, it is tempting to speculate that an effector protein downstream of
mTOR - raptor may contribute directly or indirectly to AKT activation.
mTOR - raptor complex is sensitive to rapamycin and regulates cell growth, in part, by
phosphorylation of p70S6K and subsequently rpS6 and 4E - BP1, thus promoting protein translation.
mTOR - rictor complex (composed of
mTOR, rictor, and GβL) is not rapamycin sensitive and modulates cell survival and proliferation by direct
phosphorylation of AKT on Ser473 and by facilitating AKT
phosphorylation on Thr308 by PDK1 in vitro (13).
Treatment of the Karpas 299 and SU - DHL1 cell lines with increasing concentrations of rapamycin, an inhibitor of the
mTOR - raptor complex, resulted in a marked concentration - dependent decrease of the
phosphorylation levels of
mTOR, p70S6K, 4E - BP1, and total eIF4E (Fig. 4A).
The
phosphorylation status of
mTOR, 4E - BP1, p70S6K, and rpS6 was immunohistochemically examined in 31 ALK + ALCL tumors.
We observed that the
phosphorylation level of AKT significantly correlated with the
phosphorylation level of
mTOR and rpS6 as well as with expression of total 4E - BP1 and eIF4E in ALK + ALCL tumors.
Infection of both cell lines with adeno - myrAkt resulted in substantially increased of Ser473p - AKT levels (A) associated with increased
phosphorylation (activation) of
mTOR, p70S6K, and rpS6 (B).
A and B,
phosphorylation and subcellular localization of
mTOR signaling proteins in ALCL cell lines.
The translation initiation factor, eIF4E, is an indirect target of
mTOR because it is released by
phosphorylation of its repressor 4E - BP1 by
mTOR - raptor complex, thereby stimulating cap - dependent translation (7, 11, 12).
Silencing of total
mTOR gene expression by siRNA decreased AKT
phosphorylation.
Constitutive activation of AKT resulted in a substantial increase in the
phosphorylation of
mTOR, p70S6K, and rpS6 (Fig. 3A and B).
We also show that inhibition of
mTOR with rapamycin, as well as silencing
mTOR gene product expression using
mTOR - specific small interfering RNA, decreased
phosphorylation of
mTOR signaling proteins and induced cell cycle arrest and apoptosis in ALK + ALCL cells.
In agreement with this observation, recently Sarbassov et al. (13) have shown that rictor -
mTOR (but not
mTOR - raptor) complex directly phosphorylates AKT on Ser473 and facilitates Thr308
phosphorylation by PDK1 in vitro.
C and D, the
phosphorylation status of
mTOR, p70S6K, 4E - BP1, and rpS6 was assessed immunohistochemically in a series of 31 ALK + ALCL tumors.
However, the PI3K - AKT -
mTOR pathway model seems to be more complex, as recent evidence suggests that rictor -
mTOR complex directly phosphorylates AKT on Ser473 and facilitates Thr308
phosphorylation by PDK1 in vitro and
mTOR is directly phosphorylated by p70S6K at Ser2448.
The balance between kinase and phosphatase activities determines the rate of
phosphorylation of the insulin receptor kinase domain and several downstream targets including the phosphatidylinositol phosphates, the serine / threonine kinase Akt1 and the
mTOR.
Activation of the insulin receptor leads to sequential activation of a number of protein and lipid kinases, including the serine / threonine kinases Akt1 and Akt2, which not only stimulate
mTOR and thus downregulate autophagic protein catabolism (and thus cysteine supplies), but elicit
phosphorylation (inhibition) of FOXO1, a transcription factor that induces expression of proteins involved in both of the proteolysis recycling pathways: the autophagic / lysosomal pathway and the ubiquitin - proteasomal pathway.
Endocrine responses and acute
mTOR pathway
phosphorylation to resistance exercise with leucine and whey.
BetaTOR has been shown to increase the
phosphorylation of
mTOR, thus activating the
mTOR signaling pathway in muscle.
The discordant
mTOR - p70S6K
phosphorylation with protein only and protein feedings with alcohol is not unprecedented given we [8] and others [43] have shown that
mTOR - S6K
phosphorylation often parallels changes in MPS but does not always reflect either the magnitude or duration of the increased MPS signal in humans.
Furthermore,
phosphorylation states of intracellular regulators of muscle protein synthesis (
mTOR, 70 - kDa S6 kinase, and eIF4E - BP1) were similar in pigs that consumed a leucine - supplemented, low - protein diet or a high - protein diet without additional leucine, highlighting the potential synthetic effect resulting from increased leucine intake.